Key result
Breast cancer cells acquire lipids through receptor-mediated endocytosis of intact VLDL particles, a process dependent on lipoprotein lipase bound to heparan sulfate proteoglycans and the VLDL receptor.
Population
Breast cancer cell lines and tissues
Authors
Loading...
May inform breast cancer metabolic targeting; leaves open human relevance from animal data alone.
Breast cancer cells can acquire lipids through the uptake of intact VLDL particles via LPL and VLDL receptor-mediated endocytosis, highlighting a metabolic plasticity that may compensate for therapies targeting fatty acid synthesis.
Lupien et al. (2019) studied Breast cancer. VLDL and LPL manipulation was evaluated on VLDL uptake and lipid acquisition. Breast cancer cells acquire lipids through receptor-mediated endocytosis of intact VLDL particles, a process dependent on lipoprotein lipase bound to heparan sulfate proteoglycans and the VLDL receptor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: